Hovione's sales grow 15%.(Company overview)

Hovione announced that the consolidated sales for the year ended 31 Mar 2010 amounted to $144 M, representing an increase of 15% over 2009. The company acquired an API manufacturing facility from Pfizer, in Cork, Ireland, as well as a state-of-the-art Aseptic Spray Drying (ASD) manufacturing line. Hovione also expanded its production capacity of contrast agents at the Hisyn site in China. ASD capability is core to its strategy and Hovione is committed to remaining the global industry leader in spray drying. The plant in Cork doubled Hovione's quality production capacity and will enable to capture new market opportunities. Since 2005, Hovione has increased sales by 77%, has gone from …